Pfizer vaccine distribution: Supply-chain problems hinder rollout - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

Business News News

Supply chain delays marred Pfizer's initial vaccine rollout plans, but the company still plans to deliver on the supply it promised the US

to fast-track COVID-19 vaccine development by funding research in six promising candidates. Pfizer did not receive federal funding for its research, but used money for manufacturing and distribution.

The US Food and Drug Administration could greenlight emergency authorization for two separate vaccines, made by Pfizer and Moderna. Both of the vaccines require two doses. The companies have said they will be ready to distribute vaccines within hours of an FDA emergency authorization. An independent advisory committee will meet on December 10 to decide on recommending Pfizer's vaccine to the FDA.

The UK has already allowed for use of Pfizer's vaccine. The WSJ reported the UK said in November that it could get 10 million Pfizer vaccine doses by year-end, but the expectation will now be four to five million.Do you have a personal experience with the coronavirus you'd like to share? Or a tip on how your town or community is handling the pandemic? Please emailfrom Business Insider Intelligence on how COVID-19 is affecting industries.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

JoeBiden Transition46 realDonaldTrump RajaPetra

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines